市场调查报告书
商品编码
1372540
美国数位药局市场规模和预测(2020-2030)、区域份额、趋势和成长机会分析范围:按药物类型(处方药和非处方药)、产品、平台和性别(男性和女性)US Digital Pharmacy Market Size and Forecast (2020-2030), Regional Share, Trends, and Growth Opportunity Analysis Coverage: by Drug Type (Prescription Medicine and Over-the-Counter Medicine), Product, Platform, and Gender (Male and Female) |
美国数位药局市场预计将从2022年的672.42亿美元成长到2030年的2,402.16亿美元;预计2022年至2030年复合年增长率为17.25%。COVID-19大流行期间在线购买处方药的激增以及对在线平台的日益青睐是推动美国数字药房市场增长的几个因素。
监测血糖是糖尿病管理的重要组成部分。血糖仪或血糖仪通常用于血糖监测。它涉及采集一小滴血,通常是刺破指尖并将其放在血糖仪的试纸上。血糖值以毫克每分升 (mg/dl) 为单位测量,安全血糖的标准指引范围为 70 至 180 mg/dl。
COVID-19 大流行期间在线购买处方药的激增推动了美国数位药房市场
根据 ASOP 全球基金会 2020 年发布的报告,由于便利性和成本效益,近 50% 的美国人口在网路上购买药品。 Abacus Data 对1,500 名美国消费者进行的另一项调查显示,2020 年,十分之四的美国人(42%) 在网上购买药品,从2020 年到2021 年,网上购买药品的人数增加了7 %。此外,购买趋势美国表示,美国人在网上购买一系列处方药,范围从治疗慢性和持续性疾病的产品(占所有购买量的23%),包括高血压、哮喘和糖尿病,到癌症和激素替代疗法药物等专业处方药(每项均占所有购买量的 11%)。此外,64%的人在2021年首次在网路上购买药品,并打算在疫情结束后继续在网路上购买药品。人们对网上购买药品的偏好主要是因为购买的便利性、产品的可及性以及处方药成本的降低(折扣、特价等)。 According to a survey conducted by healthinsurance.com, there was a 340% increase in telemedicine usage among Medicare recipients in the US in 2021. 33% of the increased users revealed that they preferred ordering prescription medicines through an online pharmacy during the COVID-19大流行.因此,数位药剂师数量的增加以及处方药的线上购买,再加上电子商务行业的迅速发展以及消费者行为向线上购买的大规模转变,有利于美国数位药房市场的成长。
市场趋势
基于网路的整合线上药局介面成为主要趋势
整合电子医疗保健系统与药剂师和患者可以访问的基于网路的药房介面相结合,可能会成为未来几年美国数位药房市场的新趋势。线上药局为购买药品的人提供线上支援的程式就是此类介面的一个显着例子。例如,服用他汀类药物作为治疗的一部分的患者可能会停止服药或出现服药不规则的情况。与接受过培训的药房团队成员进行提醒和即时聊天,为服用他汀类处方药的人提供依从性支持,可以帮助避免停药。
基于平台的见解
从平台来看,美国数位药局市场分为应用程式平台和网站平台。基于应用程式的应用程式进一步细分为远距医疗药房应用程式、药物管理应用程式、健康和保健应用程式、复合药房应用程式等。基于应用程式的细分市场将在 2022 年占据更大的市场份额,预计该细分市场在预测期内的复合年增长率将达到 17.60%。预计 2022 年至 2030 年期间,远距医疗药房应用程式将占据基于应用程式细分市场的最大份额。可以从任何地方透过远距医疗应用程式存取虚拟医疗保健。根据 CDC 2021 年发布的资料,2020 年有 37.0% 的成年人使用远距医疗,包括医疗服务提供者就诊、线上处方和心理健康服务。最好的远距医疗应用程式可以免费下载并且易于使用,而且它们通常完全涵盖保险服务。远距医疗药局应用程式的一些范例包括 Hims & Hers、GoodRx、K Health 和 Doctor on Demand。 GoodRx 提供低成本就诊、透过电子邮件轻鬆补充处方以及无需健康保险的就诊等服务。
根据药品类型,美国数位药局市场分为处方药和非处方药。处方药细分市场将在 2022 年占据更大的市场份额,预计该细分市场在预测期内的复合年增长率将达到 17.83%。根据产品,美国数位药局市场分为个人护理、维生素和补充剂、药物和治疗以及其他产品。药物和治疗领域进一步分为性健康、神经系统疾病、心臟保健、糖尿病、减重等。药物和治疗领域在 2022 年占据了更大的市场份额,预计该领域在预测期内的复合年增长率将达到 17.87%。从平台来看,美国数位药局市场分为应用程式平台和网站平台。基于应用程式的应用程式进一步细分为远距医疗药房应用程式、药物管理应用程式、健康和保健应用程式、复合药房应用程式等。基于应用程式的细分市场将在 2022 年占据更大的市场份额,预计该细分市场在预测期内的复合年增长率将达到 17.60%。按性别划分,市场分为男性和女性。到 2022 年,女性细分市场将占据更大的市场份额,预计该细分市场在预测期内的复合年增长率将达到 17.64%。
The US digital pharmacy market is expected to grow from US$ 67.242 billion in 2022 to US$ 240.216 billion by 2030; it is expected to grow at a CAGR of 17.25% from 2022 to 2030. Upsurge in online purchase of prescription medicines during the COVID-19 pandemic and an increasing inclination toward online platforms are a few factors driving the US digital pharmacy market growth.
Monitoring blood sugar is a vital part of diabetes management. A glucometer or blood sugar meter is commonly used for blood glucose monitoring. It involves taking a small drop of blood, usually by pricking the fingertip and placing it on the test strip in a glucometer. Blood sugar levels are measured in milligrams per deciliter (mg/dl), with standard guidelines for safe blood sugar ranging from 70 to 180 mg/dl.
Upsurge in Online Purchase of Prescription Medicines During COVID-19 Pandemic Propels US Digital Pharmacy Market
According to a report published by the ASOP Global Foundation in 2020, nearly 50% of the American population purchased medicines online due to convenience and cost benefits. As per another survey conducted by Abacus Data on 1,500 American consumers, 4 in 10 Americans (42%) purchased medicines online in 2020, recording a 7% rise in the number of online buyers of medicines from 2020 to 2021. Moreover, purchase trends in the US indicate Americans buy an array of prescription drugs online, ranging from products prescribed against chronic and ongoing conditions (23% for all purchases), including high blood pressure, asthma, and diabetes, to specialty prescriptions such as cancer and hormone replacement therapy drugs (each accounting 11% of all purchases). Additionally, 64% of the individuals purchased medicines online for the first time in 2021, with intentions to continue buying online medicine even after the pandemic ends. The preference for online buying of medicines is mainly due to the convenience of buying, accessibility to products, and reduced cost of prescription medication (discounts, special offers, etc.). According to a survey conducted by healthinsurance.com, there was a 340% increase in telemedicine usage among Medicare recipients in the US in 2021. 33% of the increased users revealed that they preferred ordering prescription medicines through an online pharmacy during the COVID-19 pandemic. Thus, an increase in the number of digital pharmacists along with online purchases of prescription medicines, coupled with the rapidly spurring e-commerce industry and a massive shift in consumer behavior toward online purchases, favors the US digital pharmacy market growth.
Market Trend
Integrated Web-Based Online Pharmacy Interface Emerges as Key Trend
Integrated e-healthcare systems incorporated with web-based pharmacy interfaces that are accessible to pharmacists and patients are likely to emerge as new trends in the US digital pharmacy market in the coming years. Programs made available by online pharmacies to provide online support to people buying medicines are a notable example of such interfaces. For instance, patients administered with statins as a part of their treatments are likely to discontinue or show irregularities in taking medicines. Reminders and live chat with a pharmacy team member trained in providing adherence support to people consuming statin-based prescribed medicines can help avoid the discontinuation of doses.
Platform-Based Insights
In terms of platform, the US digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. Telehealth pharmacy apps are expected to account for a maximum share of the market for the app-based segment during 2022-2030. Virtual healthcare can be accessed through telehealth apps from anywhere. According to CDC data published in 2021, 37.0% of adults used telemedicine in 2020, including provider visits, online prescriptions, and mental health services. The best telehealth apps can be downloaded free of cost and are easy to use, and they often completely cover insurance services. A few examples of telehealth pharmacy apps are Hims & Hers, GoodRx, K Health, and Doctor on Demand. GoodRx offers services such as low-cost visits, easy prescription refills via mail, and visits without health insurance.
Based on drug type, the US digital pharmacy market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.83% during the forecast period. Based on product, the US digital pharmacy market is segmented into personal care, vitamins & supplements, medicines & treatments, and other products. The medicine & treatments segment is further segregated as sexual health, neurological disorders, heartcare, diabetes, weight loss, and others. The medicine and treatment segment held a larger market share in 2022, and the segment is anticipated to register a higher CAGR of 17.87% during the forecast period. In terms of platform, the US digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. By gender, the market is bifurcated into males and females. The females segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.64% during the forecast period..